PRESS RELEASE published on 04/24/2025 at 22:10, 7 months 20 days ago GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update GENFIT reports full-year 2024 financial results and corporate update. Net profit of €1.5 million, Iqirvo® commercial launch in PBC, new ACLF datasets, royalty financing. CEO, Pascal Prigent shares progress and outlook Financial Results GENFIT ACLF Iqirvo® Full-year 2024
BRIEF published on 03/10/2025 at 22:15, 9 months 4 days ago GENFIT's Bondholders Approve Amendments for 2025 OCEANEs Royalty Financing Bondholders Amendments Royalty Financing GENFIT OCEANEs
PRESS RELEASE published on 03/10/2025 at 22:10, 9 months 4 days ago Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs GENFIT's 2025 OCEANEs bondholders approve amendment of terms & conditions, anticipates Royalty Financing closure. Repurchase & Consent Fee details announced Repurchase Bondholders Royalty Financing GENFIT 2025 OCEANEs
BRIEF published on 02/27/2025 at 22:15, 9 months 15 days ago GENFIT Reports Financial Metrics for 2024 Revenue Growth Cash Position Strategic Partnership Milestone Payment GENFIT Financials 2024
PRESS RELEASE published on 02/27/2025 at 22:10, 9 months 15 days ago GENFIT Announces Revenues and Cash Position as of December 31, 2024 GENFIT announces revenues of €67.0 million & cash position of €81.8 million as of Dec 31, 2024, with plans for non-dilutive capital financing deal & upcoming financial communications Revenues Cash Position Financial Communications GENFIT Non-dilutive Capital Financing
BRIEF published on 02/14/2025 at 22:15, 10 months ago GENFIT revises the conditions of its offer for the 2025 OCEANEs General Meeting Royalty Financing Bond Buyback GENFIT OCEANEs 2025
PRESS RELEASE published on 02/14/2025 at 22:10, 10 months ago GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders GENFIT announces amendment of final terms of dual proposal to 2025 OCEANEs holders, seeking consent for repurchase at EUR 32.75 per bond or a consent fee of EUR 0.90 per bond still outstanding Repurchase Amendment GENFIT Consent Fee 2025 OCEANEs
BRIEF published on 02/10/2025 at 07:35, 10 months 5 days ago GENFIT Proposes Terms for 2025 OCEANEs Bondholders Royalty Financing GENFIT Bond Repurchase Financial Terms 2025 OCEANEs
PRESS RELEASE published on 02/10/2025 at 07:30, 10 months 5 days ago GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders GENFIT announces final terms for dual proposal to the 2025 OCEANEs holders, offering to repurchase bonds at EUR 32.00 or pay a consent fee of EUR 0.60 per bond. Proposals subject to bondholders' approval and closing of royalty financing Repurchase Royalty Financing GENFIT Consent Fee 2025 OCEANEs
BRIEF published on 02/06/2025 at 22:15, 10 months 8 days ago GENFIT unveils its future clinical trials and expectations for 2025 Clinical Trials Biopharmaceutical 2025 GENFIT ACLF
Published on 12/15/2025 at 16:35, 36 minutes ago Stillwater Critical Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$15 Million
Published on 12/15/2025 at 15:00, 2 hours 11 minutes ago Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 2 hours 11 minutes ago Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 2 hours 41 minutes ago Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 3 hours 11 minutes ago Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum
Published on 12/15/2025 at 16:42, 28 minutes ago EQS-Adhoc: Vitruvia Medical AG: successfull capital increase and strengthening of the financial structure
Published on 12/15/2025 at 16:08, 1 hour 3 minutes ago Conversion of The Platform Group AG into a KGaA completed as planned
Published on 12/15/2025 at 15:50, 1 hour 20 minutes ago Original-Research: Cabka N.V. (von First Berlin Equity Research GmbH): Kaufen
Published on 12/15/2025 at 15:49, 1 hour 21 minutes ago Mutares submits an irrevocable offer to acquire Venator Ultramarine Blue Pigments business from Venator France SAS
Published on 12/15/2025 at 11:50, 5 hours 20 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 23 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/11/2025 at 08:30, 4 days 8 hours ago Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe